Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Historical Holders from Q1 2025 to Q3 2025

Symbol
KPTI on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
13,264,980
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,947,949
Holdings value
$19,279,960
% of all portfolios
0%
Number of holders
51
Number of buys
14
Number of sells
-24
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
T. Rowe Price Investment Management, Inc. 13.8% +68% $15,073,429 +$10,306,134 2,304,242 +216% T. Rowe Price Investment Management, Inc. 31 Oct 2025
Opaleye Management Inc. 9.48% $10,262,842 1,569,002 Opaleye Management Inc. 10 Oct 2025
J. WOOD CAPITAL ADVISORS LLC 4.99% $6,546,231 1,000,708 J. Wood Capital Advisors LLC 14 Oct 2025
Affinity Asset Advisors, LLC 7.83% $4,217,822 664,224 Affinity Healthcare Fund, LP 03 Apr 2025
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4.9% $4,250,895 649,984 HIGHBRIDGE CAPITAL MANAGEMENT, LLC 30 Sep 2025
JPMORGAN CHASE & CO 4.9% -6% $2,797,089 -$149,213 427,624 -5.1% JPMORGAN CHASE & CO. 30 Sep 2025
VANGUARD GROUP INC 4.7% $2,670,221 408,222 The Vanguard Group 30 Sep 2025

Institutional Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,947,949 $19,279,960 -$7,678,877 $6.54 51
2025 Q2 4,384,748 $18,898,424 +$4,718,131 $4.31 49
2025 Q1 3,312,099 $12,386,156 +$12,277,831 $3.74 47